Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Yue Pan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1958-2744; OpenAlex author ID A5100642414. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STAT3 Pathway. First author DOI 10.1002/cam4.71126↗
  2. Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells. Last author DOI 10.1093/jpp/rgaf058↗
  3. MicroRNAs in Pancreatic Cancer and Chemoresistance. Co-author DOI 10.1097/mpa.0000000000001934↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xihuang Cao · 1 shared paper, 2025 · strength 0.27
  2. Huan Tang · 1 shared paper, 2025 · strength 0.27
  3. Chunzhao Yu · 1 shared paper, 2025 · strength 0.26
  4. Hang Yin · 1 shared paper, 2025 · strength 0.26
  5. Feng Zhu · 1 shared paper, 2025 · strength 0.26
  6. Jianzhou Liu · 1 shared paper, 2021 · strength 0.15
  7. Xufeng Tao · 1 shared paper, 2021 · strength 0.15
  8. Jing Huang · 1 shared paper, 2021 · strength 0.15
  9. Gary Guishan Xiao · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.